Učitavanje...
Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
Over the years, allopurinol has been widely used as the preferred choice of urate lowering therapy in patients with gout. However, its role in patients with renal impairment is limited; and adverse reactions are well documented. Febuxostat, a newer oral non-purine xanthine oxidase inhibitor has been...
Spremljeno u:
| Izdano u: | SAGE Open Med Case Rep |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5753890/ https://ncbi.nlm.nih.gov/pubmed/29318019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17749080 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|